![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/04 | (2006.01) |
C07D 401/04 | (2013.01) | ||
A61K 31/4174 | (2006.01) | ||
A61P 21/00 | (2018.01) | ||
A61K 31/4439 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 21/00 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 3795566 |
(13) | Kind of document | T |
(96) | European patent application number | 20193962.6 |
Date of filing the European patent application | 2016-10-05 | |
(97) | Date of publication of the European application | 2021-03-24 |
(45) | Date of publication and mention of the grant of the patent | 2023-04-19 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
201562238629 P | 2015-10-07 | US | |
201562243263 P | 2015-10-19 | US | |
201662352348 P | 2016-06-20 | US |
(72) |
DOWNES, Michael , US
EVANS, Ronald, M. , US
KLUGE, Arthur , US
LAGU, Bharat , US
MIURA, Masanori , JP
PANIGRAHI, Sunil, Kumar , IN
PATANE, Michael , US
SAMAJDAR, Susanta , IN
SENAIAR, Ramesh , IN
TAKAHASHI, Taisuke , JP
|
(73) |
Mitobridge, Inc. ,
1030 Massachusetts Avenue
Suite 200, Cambridge, MA 02138,
US
The Salk Institute for Biological Studies , 10010 North Torrey Pines Road, La Jolla, CA 92037, US |
(54) | PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |
PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |